Michael is an experienced senior manager, with extensive organizational, financial, product lifecycle, marketing and business development expertise. He has led cross-disciplined teams in a wide variety of online/offline, media and communications projects, and is dedicated to disseminating the transformative science of stem & cell therapeutics via @msemporda.

Project Management | Digital Media | Strategic Planning | Business Development | Leadership | Communications | Social Marketing | OTT | Apps | Analysis | Legal | Finance | Comms | PR | Advertising | 3D | Film | TV | Animation | Music | Graphic Design

In 2008 Michael chose to investigate the emerging field of medical innovation. This decision was driven by family & issues relating to health. By applying his analytical skills he became familiar with the technologies & players involved. After years of fundamental research Michael established “@msemporda,” the dog, as a social media vehicle to focus on communicating analysis & developments in the RegenMed & Cell Therapy field. By way of independent community engagement he has built a diverse following. From his origins as an anonymous online voice supporting the sector’s investor community, to his expanding presence in social media & engagement with the scientific community, he has now established himself as a noted SciComm Analyst & Sector Advocate.

"Advocacy for Cures"​ through Social Media Outreach/Engagement & On-Site at Industry Conferences & Events. 


 youtube  scoop.it  twitter  google+  linkedin



@msemporda - Stem Cell Sector Analyst / Advocate - 2008 - Present
Santa Barbara area, California, US

Market Intelligence, Science Due Diligence, Content Dissemination, Educational Awareness & Patient Advocacy

The dog "msemporda"​ is the handle. The mission is bridging translational science via business analysis, mkt. support, scicomm education, outreach & engagement: "Advocacy for Cures."​ The means is via social media reporting, commentary & sector engagement.

Active on various public & community platforms - Blogger, Twitter, Scoop.it!, G+ & via dedicated scientific forums, including as a contributor to CCRM's SignalsPaul Knoepfler's BlogStem Cell Assays by Alexey Bersenev.

Specific and targeted science reporting, due diligence reviews, news feeds, commentary and analysis with regular postings on scientific developments, data reviews, information dissemination, business news reporting, financial/legal due diligence, patient advocacy, commentary & debate in a manner relevant & pertinent to all sector stakeholders.

msemporda's editorial direction & content creation at InvestorStemCell.com positioned "iCell"​ as an active voice in the Regenerative Medicine sector, specifically Stem Cell Therapeutics. This dedicated online community was devoted to investigating the various aspects of stem science & public companies in the field. Contributors made the forum one of the most dynamic & widely read social media sites in the sector. During Michael's tenure iCell's readership #s regularly hit monthly page views over 1 million & 100k unique IPs, capturing a wide spectrum of Industry, Scientific, Govt., Patient, Advocacy, Investor & Public readers.

3D Media International - Operations Project Manager > MediaTech Consultant - 2004 – Present Santa Barbara, California Area

Overseas venture arm of 3D Media Group, dedicated to establishing and servicing international distributors & resellers of 3D Impact Graphics solutions. Until mid-2016 based out of Barcelona, Spain. Positioned the product portfolio to include MediaTech solutions for advertising / promotional led digital applications and transitioned to work directly with US clients.

Currently consulting on the MVP build of a new OTT video service for nuTV Inc., an internet TV studio venture, as development advisor in the platform architecture planning, team recruitment and vendor procurement. Role includes ongoing business case analysis, financial modelling and application design for the operation’s product launch development cycle.

Client img: nuTV Inc.